{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T13:35:37Z","timestamp":1769348137586,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,24]]},"DOI":"10.7759\/cureus.102204","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:11:46Z","timestamp":1769263906000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Efficacy and Safety of Vasopressors and Inotropes in Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Network Meta Analysis of Randomized and Observational Studies"],"prefix":"10.7759","author":[{"given":"Ahmed Osman Hassan","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrukh","family":"Ameer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad A","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad S","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer A","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Hany","family":"Elmasry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahd","family":"Alrumaih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled Ahmed Reda","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Alghannami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara S","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa A","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv051","article-title":"Management of cardiogenic shock","volume":"36","author":"Thiele H","year":"2015","unstructured":"Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogenic shock. Eur Heart J. 2015, 36:1223-30. 10.1093\/eurheartj\/ehv051","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-year trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger RV","year":"2008","unstructured":"Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008, 149:618-26. 10.7326\/0003-4819-149-9-200811040-00005","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds HR","year":"2008","unstructured":"Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008, 117:686-97. 10.1161\/CIRCULATIONAHA.106.613596","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen S","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, et al.. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017, 136:e232-68. 10.1161\/CIR.0000000000000525","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.01.016","article-title":"Inotropes","volume":"63","author":"Francis GS","year":"2014","unstructured":"Francis GS, Bartos JA, Adatya S. Inotropes. J Am Coll Cardiol. 2014, 63:2069-78. 10.1016\/j.jacc.2014.01.016","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer D","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, et al.. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010, 362:779-89. 10.1056\/NEJMoa0907118","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1074248418797357","article-title":"Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock","volume":"24","author":"Lewis TC","year":"2019","unstructured":"Lewis TC, Aberle C, Altshuler D, Piper GL, Papadopoulos J. Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock. J Cardiovasc Pharmacol Ther. 2019, 24:130-8. 10.1177\/1074248418797357","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew R","year":"2021","unstructured":"Mathew R, Di Santo P, Jung RG, et al.. Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med. 2021, 385:516-25. 10.1056\/NEJMoa2026845","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev VS","year":"2002","unstructured":"Moiseyev VS, P\u00f5der P, Andrejevs N, et al.. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002, 23:1422-32. 10.1053\/euhj.2001.3158","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.04.143","article-title":"Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty","volume":"127","author":"Samimi-Fard S","year":"2008","unstructured":"Samimi-Fard S, Garc\u00eda-Gonz\u00e1lez MJ, Dom\u00ednguez-Rodr\u00edguez A, Abreu-Gonz\u00e1lez P. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty. Int J Cardiol. 2008, 127:284-7. 10.1016\/j.ijcard.2007.04.143","journal-title":"Int J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for\u00a0cardiogenic shock after acute\u00a0myocardial infarction","volume":"72","author":"Levy B","year":"2018","unstructured":"Levy B, Clere-Jehl R, Legras A, et al.. Epinephrine versus norepinephrine for\u00a0cardiogenic shock after acute\u00a0myocardial infarction. J Am Coll Cardiol. 2018, 72:173-82. 10.1016\/j.jacc.2018.04.051","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-022-02337-7","article-title":"Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis","volume":"69","author":"Fernando SM","year":"2022","unstructured":"Fernando SM, Mathew R, Sadeghirad B, et al.. Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis. Can J Anaesth. 2022, 69:1537-53. 10.1007\/s12630-022-02337-7","journal-title":"Can J Anaesth"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277087","article-title":"Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock","volume":"17","author":"Na SJ","year":"2022","unstructured":"Na SJ, Yang JH, Ko RE, et al.. Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock. PLoS One. 2022, 17:e0277087. 10.1371\/journal.pone.0277087","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-025-02742-0","article-title":"Milrinone versus dobutamine in acute myocardial infarction-related cardiogenic shock; a propensity score matched analysis","volume":"114","author":"Ten Berg S","year":"2025","unstructured":"Ten Berg S, Bogerd M, Peters EJ, et al.. Milrinone versus dobutamine in acute myocardial infarction-related cardiogenic shock; a propensity score matched analysis. Clin Res Cardiol. 2025, 114:1414-26. 10.1007\/s00392-025-02742-0","journal-title":"Clin Res Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton B","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al.. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015, 162:777-84. 10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","article-title":"Cochrane Handbook for Systematic Reviews of Interventions. 2nd Ed","author":"Higgins JPT","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J, et al.. Cochrane Handbook for Systematic Reviews of Interventions. 2nd Ed. John Wiley & Sons, Hoboken, NJ; 2019. 10.1002\/9781119536604"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"R\u00fccker G","year":"2012","unstructured":"R\u00fccker G. Network meta-analysis, electrical networks and graph theory. Res Synth Methods. 2012, 3:312-24. 10.1002\/jrsm.1058","journal-title":"Res Synth Methods"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/9781119558378","article-title":"Introduction to Meta-Analysis","author":"Borenstein M","year":"2021","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Wiley, Hoboken, NJ; 2021. 10.1002\/9781119558378"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti G","year":"2014","unstructured":"Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 2014, 9:e99682. 10.1371\/journal.pone.0099682","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias S","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010, 29:932-44. 10.1002\/sim.3767","journal-title":"Stat Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/0470870168.ch14","article-title":"Assessing the evolution of effect sizes over time","author":"Trikalinos TA","year":"2005","unstructured":"Trikalinos TA, Ioannidis JPA. Assessing the evolution of effect sizes over time. Publication Bias in Meta-Analysis. Rothstein HR, Sutton AJ, Borenstein M (ed): Wiley, Hoboken, NJ; 2005. 241-59. 10.1002\/0470870168.ch14"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1501500403","article-title":"Visualizing assumptions and results in network meta-analysis: the network graphs package","volume":"15","author":"Chaimani A","year":"2015","unstructured":"Chaimani A, Salanti G. Visualizing assumptions and results in network meta-analysis: the network graphs package. Stata J. 2015, 15:905-50. 10.1177\/1536867X1501500403","journal-title":"Stata J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/0470870168.ch6","article-title":"Regression methods to detect publication and other bias in meta-analysis","author":"Sterne JAC","year":"2005","unstructured":"Sterne JAC, Egger M. Regression methods to detect publication and other bias in meta-analysis. Publication Bias in Meta-Analysis. Rothstein HR, Sutton AJ, Borenstein M (ed): Wiley, Hoboken, NJ; 2005. 99-110. 10.1002\/0470870168.ch6"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/0470870168.ch8","article-title":"The trim and fill method","author":"Duval S","year":"2005","unstructured":"Duval S. The trim and fill method. Publication Bias in Meta-Analysis. Rothstein HR, Sutton AJ, Borenstein M (ed): Wiley, Hoboken, NJ; 2005. 127-44. 10.1002\/0470870168.ch8"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxq046","article-title":"Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis","volume":"12","author":"R\u00fccker G","year":"2011","unstructured":"R\u00fccker G, Schwarzer G, Carpenter JR, Binder H, Schumacher M. Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis. Biostatistics. 2011, 12:122-42. 10.1093\/biostatistics\/kxq046","journal-title":"Biostatistics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","article-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen J","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates, Mahwah, NJ; 1988. 10.4324\/9780203771587"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev J","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008, 61:64-75. 10.1016\/j.jclinepi.2007.03.013","journal-title":"J Clin Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2013.08.042","article-title":"Long term effects of levosimendan therapy in patients with cardiogenic shock","volume":"84","author":"Katsytadze I","year":"2013","unstructured":"Katsytadze I, Amosova E, Prudkyi I, et al.. Long term effects of levosimendan therapy in patients with cardiogenic shock. Resuscitation. 2013, 84:S11. 10.1016\/j.resuscitation.2013.08.042","journal-title":"Resuscitation"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.1599","article-title":"Dobutamine versus milrinone use in acute myocardial infarction related cardiogenic shock","volume":"44","author":"ten Berg S","year":"2023","unstructured":"ten Berg S, Peters EJ, Bogerd M, et al.. Dobutamine versus milrinone use in acute myocardial infarction related cardiogenic shock. Eur Heart J. 2023, 44:ehad655.1599. 10.1093\/eurheartj\/ehad655.1599","journal-title":"Eur Heart J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2021.04.005","article-title":"Assessing the hemodynamic impact of various inotropes combination in patients with cardiogenic shock with Non-ST elevation myocardial infarction -the ANAPHOR study","volume":"73","author":"Sharma K","year":"2021","unstructured":"Sharma K, Charaniya R, Champaneri B, et al.. Assessing the hemodynamic impact of various inotropes combination in patients with cardiogenic shock with Non-ST elevation myocardial infarction -the ANAPHOR study. Indian Heart J. 2021, 73:572-6. 10.1016\/j.ihj.2021.04.005","journal-title":"Indian Heart J"},{"key":"ref33","article-title":"Shock following myocardial infarction: a clinical survey of 140 cases","volume":"93","author":"Cronin RF","year":"1965","unstructured":"Cronin RF, Moore S, Marpole DG. Shock following myocardial infarction: a clinical survey of 140 cases. Can Med Assoc J. 1965, 93:57-63.","journal-title":"Can Med Assoc J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1971.11716793","article-title":"[Shock states during myocardial infarct: treatment of cardiogenic shock with dopamine]","volume":"26","author":"Andriange M","year":"1971","unstructured":"Andriange M, Calay G, Gach J, Lisin N. [Shock states during myocardial infarct: treatment of cardiogenic shock with dopamine]. Acta Clin Belg. 1971, 26:249-61. 10.1080\/17843286.1971.11716793","journal-title":"Acta Clin Belg"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s8856","article-title":"Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction","volume":"6","author":"Omerovic E","year":"2010","unstructured":"Omerovic E, R\u00e5munddal T, Albertsson P, et al.. Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction. Vasc Health Risk Manag. 2010, 6:657-63. 10.2147\/vhrm.s8856","journal-title":"Vasc Health Risk Manag"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.1.248","article-title":"Effect of protracted dobutamine infusion on survival of patients in cardiogenic shock treated with intraaortic balloon pumping","volume":"103","author":"Moulopoulos SD","year":"1993","unstructured":"Moulopoulos SD, Stamateolopoulos SF, Nanas JN, Kontoyannis DA, Nanas SN. Effect of protracted dobutamine infusion on survival of patients in cardiogenic shock treated with intraaortic balloon pumping. Chest. 1993, 103:248-52. 10.1378\/chest.103.1.248","journal-title":"Chest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/17482940701358564","article-title":"Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction","volume":"10","author":"Christoph A","year":"2008","unstructured":"Christoph A, Prondzinsky R, Russ M, et al.. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction. Acute Card Care. 2008, 10:49-57. 10.1080\/17482940701358564","journal-title":"Acute Card Care"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e318167378f","article-title":"Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states","volume":"30","author":"Levy B","year":"2008","unstructured":"Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock. 2008, 30:417-21. 10.1097\/SHK.0b013e318167378f","journal-title":"Shock"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318232962a","article-title":"Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies","volume":"40","author":"Landoni G","year":"2012","unstructured":"Landoni G, Biondi-Zoccai G, Greco M, et al.. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med. 2012, 40:634-46. 10.1097\/CCM.0b013e318232962a","journal-title":"Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455333-comparative-efficacy-and-safety-of-vasopressors-and-inotropes-in-acute-myocardial-infarction-related-cardiogenic-shock-a-systematic-review-and-network-meta-analysis-of-randomized-and-observational-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:11:47Z","timestamp":1769263907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455333-comparative-efficacy-and-safety-of-vasopressors-and-inotropes-in-acute-myocardial-infarction-related-cardiogenic-shock-a-systematic-review-and-network-meta-analysis-of-randomized-and-observational-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.102204","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,24]]}}}